What are the appropriate dosing, indications, and contraindications for Emetrol (phosphorated carbohydrate solution) in adults, adolescents, and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emetrol (Phosphorated Carbohydrate Solution)

Direct Answer

Emetrol is an over-the-counter phosphorated carbohydrate solution indicated for nausea and upset stomach in adults and children ≥2 years of age, with specific dosing based on age, but it should not be used in children under 2 years. 1

Active Ingredients and Mechanism

Emetrol contains a phosphorated carbohydrate solution with the following per 5 mL: 1

  • Dextrose (glucose): 1.87 g
  • Levulose (fructose): 1.87 g
  • Phosphoric acid: 21.5 mg

The mechanism involves slowing gastric emptying through the combined effects of carbohydrates and phosphoric acid, which empirically reduces nausea and vomiting. 2

Dosing Recommendations

Adults and Children ≥12 Years

  • Dose: 1-2 tablespoons (15-30 mL) 1
  • Frequency: Repeat every 15 minutes until distress subsides 1
  • Maximum: Do not exceed 5 doses in 1 hour without consulting a physician 1

Children 2 to <12 Years

  • Dose: 1-2 teaspoons (5-10 mL) 1
  • Frequency: Repeat every 15 minutes until distress subsides 1
  • Maximum: Do not exceed 5 doses in 1 hour without consulting a physician 1

Children <2 Years

  • Contraindicated: Not recommended for use in this age group 1

Administration Instructions

Critical administration requirements to maximize effectiveness: 1

  • Never dilute the product
  • Do not drink fluids of any kind immediately before or after taking Emetrol
  • Measure only with the dosing cup provided with the product
  • The dosing cup should be used exclusively with Emetrol and not with other products

Clinical Context and Limitations

Comparison to Evidence-Based Antiemetics

While Emetrol is available over-the-counter for symptomatic nausea relief, it is important to recognize that for acute gastroenteritis in children <4 years, antiemetic medications (including suppositories) are not recommended because safety and efficacy have not been established. 3 The primary treatment for vomiting in young children remains oral rehydration solution (ORS), not antiemetic agents. 3

For children ≥4 years with acute gastroenteritis, ondansetron may be considered to facilitate oral rehydration, but this represents a different clinical scenario with stronger evidence. 3, 4

Important Clinical Pitfalls

Do not use Emetrol as a substitute for proper fluid and electrolyte replacement in children with vomiting from gastroenteritis—ORS remains the cornerstone of therapy. 3

Do not use in infants <2 years as there is no safety or efficacy data in this population, and the FDA labeling explicitly excludes this age group. 1

Avoid in patients with diabetes mellitus given the high carbohydrate content (3.74 g per 5 mL dose), which could affect blood glucose control. 1

Recognize red-flag symptoms that require immediate evaluation rather than symptomatic treatment: bilious vomiting, forceful/projectile vomiting, abdominal distension, bloody stools, or altered mental status warrant urgent assessment for surgical obstruction. 3

Product Availability

Emetrol is available as a 12 oz (355 mL) oral liquid formulation. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.